‘Adenomyosis may be invisible, its impact is not’

• Adenomyosis: Key Clinical Takeaways
• Adenomyosis affects approximately 1 in 10 women, but remains underrecognised and underdiagnosed due to patient symptom dismissal in clinical practice
• Patient pain and suffering from adenomyosis is frequently invalidated by healthcare providers, contributing to delayed diagnosis and treatment initiation
• Despite being a common condition with significant clinical impact, adenomyosis requires improved clinician awareness and validation of patient symptoms for better outcomes

One in 10 women live with adenomyosis yet sufferers say their pain is often dismissed.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.